GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » eFFECTOR Therapeutics Inc (FRA:LWK) » Definitions » Total Stockholders Equity

eFFECTOR Therapeutics (FRA:LWK) Total Stockholders Equity : €0.76 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is eFFECTOR Therapeutics Total Stockholders Equity?

eFFECTOR Therapeutics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €0.76 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. eFFECTOR Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was €0.20. The ratio of a company's debt over equity can be used to measure how leveraged this company is. eFFECTOR Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2024 was 24.48.

eFFECTOR Therapeutics Total Stockholders Equity Historical Data

The historical data trend for eFFECTOR Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

eFFECTOR Therapeutics Total Stockholders Equity Chart

eFFECTOR Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
-108.71 15.30 3.68 -5.31

eFFECTOR Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.50 2.38 -3.72 -5.31 0.76

eFFECTOR Therapeutics  (FRA:LWK) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

eFFECTOR Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(0.761-0)/3.90231
=0.20

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

eFFECTOR Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(18.463 + 0.165) / 0.761
=24.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

eFFECTOR Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of eFFECTOR Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

eFFECTOR Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » eFFECTOR Therapeutics Inc (FRA:LWK) » Definitions » Total Stockholders Equity
Comparable Companies
CGTX VTVT PVCT PMN ELDN NERV INKT COEP PASG HOOK OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
EFTR:USA
Address
142 North Cedros Avenue, Suite B, Solana Beach, CA, USA, 92075
Website
https://www.effector.com
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

eFFECTOR Therapeutics Headlines

No Headlines